Sebastiaan Tuyls

Kortrijk, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Cytoreduction is a Valid Option for Treatment and Prevention of Anaphylaxis in Systemic Mastocytosis: Case Report and Literature Review.

Cytoreduction is a Valid Option for Treatment and Prevention of Anaphylaxis in Systemic Mastocytosis: Case Report and Literature Review.

Journal: Clinical reviews in allergy & immunology

Published: November 16, 2025

Sniffing out safety: canine detection and identification of SARS-CoV-2 infection from armpit sweat.

Sniffing out safety: canine detection and identification of SARS-CoV-2 infection from armpit sweat.

Journal: Frontiers in medicine

Published: March 14, 2023

Endotyping of IgE-Mediated Polyethylene Glycol and/or Polysorbate 80 Allergy.

Endotyping of IgE-Mediated Polyethylene Glycol and/or Polysorbate 80 Allergy.

Journal: The journal of allergy and clinical immunology. In practice

Published: June 17, 2022

Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study.

Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study.

Journal: Research and practice in thrombosis and haemostasis

Published: June 14, 2022

Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI).

Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI).

Journal: Acta clinica Belgica

Published: April 01, 2021

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.

Journal: Trials

Published: December 30, 2020

A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.

A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.

Journal: Trials

Published: August 05, 2020

Allergic reactions to polyethoxylated castor oil derivatives: A guide to decipher confusing names on pharmaceutical labels.

Allergic reactions to polyethoxylated castor oil derivatives: A guide to decipher confusing names on pharmaceutical labels.

Journal: The journal of allergy and clinical immunology. In practice

Published: June 22, 2019

Determinants of survival in lung transplantation patients with idiopathic pulmonary fibrosis: a retrospective cohort study.

Determinants of survival in lung transplantation patients with idiopathic pulmonary fibrosis: a retrospective cohort study.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: June 06, 2018

Subgroups in cephalosporin allergy, making a patient-tailored approach redundant?

Subgroups in cephalosporin allergy, making a patient-tailored approach redundant?

Journal: The Journal of allergy and clinical immunology

Published: July 31, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026